Selective expansion of regulatory T cells during lenalidomide treatment of myelodysplastic syndrome with isolated deletion 5q
Ekaterina Balaian(University Hospital Carl Gustav Carus), Martin Wermke(National Center for Tumor Diseases), Martin Bornhäuser(Technische Universität Dresden), Claudia Schuster(University Hospital Carl Gustav Carus), Claudia Schönefeldt(Innsbruck Medical University), Rainer Ordemann, Uwe Platzbecker(National Center for Tumor Diseases), Malte von Bonin(Städtisches Klinikum Dresden), Detlef Haase(Universitätsmedizin Göttingen), Sebastian Tuve, Brigitte Mohr(Klinik und Poliklinik für Psychotherapie und Psychosomatik), Gerhard Ehninger(University Hospital Carl Gustav Carus), Ulrich Germing(Heinrich Heine University Düsseldorf), Uta Oelschlaegel(University Hospital Carl Gustav Carus)
Cited by 12
Related Papers
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k